Clinical trial
Post-Operative Nausea And Vomiting Study In Female Patients
NCT00274690 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00274690 |
|---|---|
| Title | Post-Operative Nausea And Vomiting Study In Female Patients |
| Official title | A Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing With GW679769 (50 mg or 150 mg) for Three Consecutive Days When Administered With a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative |
| Intervention type | Drug |
| Interventions | GW679769 |
| Enrollment | 435 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jan 11, 2006 |
| Last update posted | Jan 20, 2017 |
| Countries | Denmark, Hong Kong, Hungary, Israel, Norway, Philippines, Slovenia, Spain, Thailand, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: